|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2842573 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14188785.1 |
| Date of filing the European patent application | 2009-11-06 | |
| (97) | Date of publication of the European application | 2015-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-27 |
| (46) | Date of publication of the claims translation | 2017-12-11 |
| (30) | Number | Date | Country code |
| 112686 P | 2008-11-07 | US | |
| 164870 P | 2009-03-30 | US |
| (72) |
Kim, Kyung Jin, US
Zhao, Wei-Meng, US
Park, Hangil, US
|
| (73) |
Galaxy Biotech, LLC,
22830 San Juan Road, Cupertino CA 95014,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Monokloniniai antikūnai prieš fibroblastų augimo faktoriaus receptorių-2 |
| Monoclonal antibodies to Fibroblast Growth Factor receptor 2 |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 17 | 347.00 EUR |
| 2026-11-06 |